Background. Control of warm ischemia (WI) lesions that occur with donation after circulatory death (DCD) would significantly increase the donor pool for liver transplantation. We aimed to determine whether a novel, oxygenated and hypothermic machine perfusion device (HMP Airdrive system) improves the quality of livers derived from DCDs using a large animal model. Methods. Cardiac arrest was induced in female large white pigs by intravenous injection of potassium chloride. After 60 minutes of WI, livers were flushed in situ with histidine-tryptophan-ketoglutarate and subsequently preserved either by simple cold storage (WI-SCS group) or HMP (WI-HMP group) using Belzer-MPS solution. Liver grafts procured from heart-beating donors and preserved by SCS served as controls. After 4 hours of preservation, all livers were transplanted. Results. All recipients in WI-SCS group died within 6 hours after transplantation. In contrast, the HMP device fully protected the liver against lethal ischemia/reperfusion injury, allowing 100% survival rate. A postreperfusion syndrome was observed in all animals of the WI-SCS group but none of the control or WI-HMP groups. After reperfusion, HMP-preserved livers functioned better and showed less hepatocellular and endothelial cell injury, in agreement with better-preserved liver histology relative to WI-SCS group. In addition to improved energy metabolism, this protective effect was associated with an attenuation of inflammatory response, oxidative load, endoplasmic reticulum stress, mitochondrial damage, and apoptosis. Conclusions. This study demonstrates for the first time the efficacy of the HMP Airdrive system to protect liver grafts from lethal ischemic damage before transplantation in a clinically relevant DCD model.
L iver grafts procured after circulatory death (DCDs) might increase the pool of organs by up to 20%. 1 However, many centers remain reluctant to use those grafts due to jeopardized graft function posttransplantation. 2 By definition, warm ischemia (WI) is unavoidable for such organs with an increased risk of primary nonfunction (PNF) and ischemic cholangiopathy, leading to increased morbidity and ultimately graft failure. 3, 4 To prevent ischemia-related complications, hypothermic machine perfusion (HMP) has regained interest to overcome the limits of standard simple cold storage (SCS). Unlike SCS, HMP maintains oxygen supply to the cold organ, preserving its ability to synthesize adenosine triphosphate (ATP). 5 HMP has been shown to be more effective than SCS in experimental models, [6] [7] [8] [9] [10] and preliminary clinical studies. [11] [12] [13] [14] Guarrera et al 11 were the first to report in humans the safety of an HMP device without active oxygenation of the perfusion fluid. Another device using an oxygenated perfusate delivered at low pressure through the portal vein (system hypothermic oxygenated perfusion) has been used in the clinical setting and demonstrated better protection of DCD livers than SCS. 13, 14 Notably, these 2 devices are not transportable and can be used only at the receiving hospital after SCS, before implantation. Intuitively, perfusion of the liver beginning at the donor site and maintained until the implantation might be more protective than end-ischemic perfusion (EIP). To this end, an innovative HMP device (Airdrive, Amsterdam, The Netherlands) has been developed as a mobile and disposable perfusion system for solid organ storage ( Figure 1A ). This device has shown a beneficial effect in experimental hypothermic preservation of kidney and liver allografts. 15, 16 Further, the Airdrive is the first transportable oxygenated HMP unit for liver preservation. Using a clinically relevant DCD model in the pig, we determined whether this new perfusion system improves donor liver viability for transplantation.
MATERIALS AND METHODS

Animals
This study was performed in female large white pigs (25-30 kg) in accordance with French Ministry of Agriculture and local ethical committee (protocol number 14-032). Animals were fasted with free access to water 24 hours before surgery. All animals were premedicated with intramuscular 20 mg ketamine. General anesthesia was induced with intravenous administration of 4 to 5 mg/kg propofol. After endotracheal intubation and mechanical ventilation, anesthesia was maintained by inhalation of isoflurane (0.2-1.5%) and repeated bolus of sufentanil depending on the animals' need.
Experimental Design
Donor death was induced by intravenous injection of potassium chloride under full anesthesia. Cardiac arrest occurred immediately, and mechanical ventilation was stopped. The animal was subsequently left untouched for 45 minutes, resulting in a time interval of 60 minutes between cardiac arrest and in situ cooling. No heparin was given to animals before or during the warm ischemic insult. Liver allografts procured from heart-beating donors and preserved by SCS served as controls. Animals were divided into 3 groups:
i. In control group (n = 6), livers from heart-beating donors were cold flushed with histidine-tryptophan-ketoglutarate (HTK) solution (Eusapharma, Limonest, France) immediately after aortic cross clamping (ie, without WI), and then preserved by SCS in HTK solution at 4°C.
ii. In WI-SCS group (n = 4), livers were exposed to 60 minutes WI, cold flushed with HTK solution, and subsequently preserved by SCS in HTK solution at 4°C. iii. In WI-HMP group (n = 6), livers were exposed to 60 minutes WI, cold flushed with HTK solution, and subsequently preserved by HMP in combination with University of Wisconsin machine perfusion (MP) solution (Belzer-MPS, Bridge To Life, Columbia, SC) under hypothermic conditions (2-6°C) ( Figure 1A ).
After 4 hours of preservation, all liver allografts were orthotopically transplanted into recipient animals.
Donor Operation
Harvesting procedure and bench preparation were performed in all animals as previously described. 17 In MP livers, cannulation of the hepatic artery and portal vein was accomplished with single use and specifically designed perfusion cannulas of appropriate size.
SCS
After washout, grafts were placed in a sterile bag filled with 500 mL of HTK solution, and subsequently stored at 4°C.
MP With the Airdrive
The MP device Airdrive (Amsterdam Medical Center spinoff SME Oxiplenish) was used ( Figure 1A ). This lightweight transportable (fully operational 11 kg) and disposable MP system is based on an oxygen-driven positive displacement pump that allows pressure-controlled pulsatile perfusion and oxygenation of the perfusion medium by means of a specially designed oxygenator. 15, 16 The oxygen is provided by a standard onboard 2-L pressurized cylinder containing medical grade oxygen (Air Liquide). A 12-V, nonrechargeable battery powers the gas valves and pressure feedback systems via a proportionalintegral-derivative controller. Cold packs are used to keep the temperature of the system at less than 10°C. The allograft is perfused until implantation via portal and artery systems using 1.5 L of refrigerated Belzer-MPS. The vascular resistance generated by the liver graft regulates the perfusion flow, not exceeding 200 mL/min. A software-embedded maximum pressure limit prevents overshoot of pressure to the organ. Perfusion flow and pressure, intrahepatic vascular resistance, perfusion time as well as temperature are continuously recorded and visualized on a LCD display throughout HMP ( Figure 1A) . Samples of the perfusate can be collected at regular time interval and analyzed for oxygenation using an automatic analyzer.
Orthotopic Liver Transplantation
All animals underwent the same orthotopic transplantation procedure including flush with cold albumin before reperfusion, as previously described. 17 Electrocardiographic activity, body temperature, and diuresis were continuously monitored. In each recipient animal, polyethylene catheters were placed in the left internal jugular vein for infusion and left carotid artery for continuous monitoring. Immediately before removal of the native liver, a passive venovenous shunt was established between the portal vein and left external jugular vein to maintain stable hemodynamic conditions during the anhepatic phase. As well, 500 mL of plasmion solution was infused into the recipient just before and during the anhepatic phase A Pulse index Continuous Cardiac Output system (Pulsion Medical Systems SE, France) was used to monitor heart rate, arterial blood pressure, and cardiac output. Sedation was stopped, and the animals were extubated immediately after operation, and subsequently taken to their cage with heat lamps. Analgesia was given by means of subcutaneous injection of 0.3 mg buprenorphine 1 hour after tracheal extubation. No immunosuppression was given after liver transplantation (LT).
Monitoring of Animal and Liver Allograft Function
Continuous monitoring was performed for 5 days after transplantation. Arterial blood gas, glycemia, and electrolyte analysis was performed at regular interval during the first hours posttransplant. The primary outcome measure was 5-day survival. Animals were monitored daily with regards to PNF defined as an aggravated form of reperfusion injury resulting in irreversible graft failure: irreversible metabolic acidosis (pH <7.1 and lactate >7 mmol/L), irreversible hypoglycemia, minimal or absent bile production and severe coagulopathy (prothrombin time <20%, international normalized ratio [INR] >4) with no identifiable technical cause. 18 Blood samples were collected before laparotomy (baseline) and at 5, 60, and 180 minutes after reperfusion, and daily thereafter until postoperative day 5 and/or sacrifice of the animal. Blood was immediately centrifuged, and the plasma was frozen and stored at −20°C until analysis.
Liver biopsies were collected before (baseline) and at the end of the preservation period, and after LT (60 minutes after reperfusion and at postoperative day 5 in surviving animals). They were either snap frozen in liquid nitrogen and stored at −80°C or preserved in 10% formaldehyde for further analysis.
Recipients were sacrificed under general anesthesia by an i.v. overdose of sodium pentobarbital at the end of the study period, or earlier when they were judged to be suffering. An autopsy was performed in all cases.
Biochemical Determinations
Hepatocellular injury (aspartate aminotransferase [AST], alanine aminotransferase [ALT]), liver (INR, total bilirubin) and kidney function (creatinine) were determined using standard biochemical methods (clinical grade). Sinusoidal endothelial cells (SEC) injury was evaluated by the measurement of purine nucleotide phosphorylase (PNP) activity using an enzymatic method. 19 To evaluate energy metabolism, we quantified ATP reserves in livers after preservation as well as ATP recovery after transplantation, using a bioluminescence diagnostic kit (Sigma Aldrich, St Quentin, France). TNF-α is a well-known mediator during ischemia/reperfusion (I/R) injury. 20 TNF-α levels were quantified using porcine enzyme-linked immunosorbent assay (ELISA) kits from BD Bio-sciences (San Diego, CA). Lipid peroxidation was used as an indirect measurement of the oxidative stress induced by reactive oxygen species, 21 and was determined in whole liver homogenates by the quantification of malondialdehyde (MDA) using the thiobarbituric acid reactive substances assay kit from Interchim (Montluçon, France). Catalase and superoxide dismutase (SOD) activities were determined by using, respectively, colorimetric and spectrophotometric assay kit from Interchim (Montluçon, France). We looked at endoplasmic reticulum (ER) stress through the determination of the ER chaperone 78-kDa glucose-regulated/binding immunoglobulin protein (GRP78) and C/EBP homologous protein (CHOP), an effector of ER stress involved in apoptosis and deoxyribonucleic acid (DNA) damage, 22 using porcine ELISA kits from MyBioSource (San Diego, CA). A fluorometric assay kit was obtained from Biovision (Palo Alto, CA) to determine liver caspase-12 activity, this protease being involved in the initiation of ER stress-induced cell death. 23 Glutamate dehydrogenase (GLDH), an enzyme that indicates mitochondrial damages, was measured in plasma samples using an enzymatic method as previously described. 24 Cytochrome C activity in plasma was evaluated using porcine ELISA kit from MyBioSource. Frozen tissue samples weighing 100 mg were homogenized in 1 mL of Phosphate-buffered saline, and supernatant was collected to determine caspase-9 activity by using a colorimetric assay kit from Biovision. Liver caspase-3 activity was measured using a colorimetric assay kit (Biovision).
Histology and Immunohistological Terminal Deoxynucleotidyl Transferase-Mediated dUTP-Biotin Nick End Labeling Assay
Histological hematoxylin/eosin and immunohistological terminal deoxynucleotidyl Transferase-mediated dUTP-biotin Nick End Labeling (TUNEL) analysis were performed on liver tissue specimens to appraise the degree of hepatic injury by optical microscopy and apoptosis, respectively. Histological lesions on stained sections were graded on a scale as previously described, taking into account the extent and severity of 7 morphological features and resulting in a score ranging between 0 and 47. 25, 26 Apoptosis was assessed by TUNEL assay (Roche Molecular Biochemical's, Mannheim, Germany) as described elsewhere. 21 Histological evaluation of damage score and ratio of the apoptotic cell number were performed in a blinded fashion by 2 experienced liver pathologists.
Statistical Analysis
Data were expressed as the means ± SD. Data were analyzed using Graph Pad Prism software (Version 6.0; Graph Pad, San Diego, CA). Statistical analyses were performed by a Kruskal-Wallis 1-way analysis-of-variance-by-ranks-test followed by a nonparametric Mann-Whitney-Wilcoxon U test when the overall comparison of groups was significant. A survival analysis was calculated according to a Kaplan Meier (Logrank test). A P value below 0.05 was considered significant.
RESULTS
Operative Characteristics
The operative characteristics did not significantly differ between groups (Table 1) .
Perfusion Parameters
The perfusion parameters in the Airdrive system were stable during the perfusion period ( Figures 1B and C ). Blood gas analysis before cannulation of the liver yielded a pO 2 of 342 ± 22 mm Hg. After graft placement in the Airdrive, the pO 2 dropped immediately to 126 ± 15 mm Hg and remained stable thereafter.
Airdrive Improved Hemodynamic Profiles After Transplantation
During the anhepatic phase, hemodynamic and respiratory parameters were similar between groups. A postreperfusion syndrome was observed in all animals that received a SC stored liver after 60 minutes WI (WI-SCS group) compared with none of the control or HMP groups. At 1-hour postreperfusion, mean arterial pressure and cardiac output decreased in WI-SCS group compared with controls (49 ± 15 mm Hg vs 67.6 ± 24 mm Hg, P = 0.04 and 2.62 ± 1.5 L/min vs 4.21 ± 0.58 L/min, P = 0.02, respectively) and machine perfused livers (49 ± 15 mm Hg vs. 59 ± 13 mm Hg, P = 0.33 and 2.62 ± 1.5 vs 4.03 ± 1.35 L/min, P = 0.5, respectively). Accordingly, catecholamine needs after reperfusion were increased in WI-SCS group (34.0 ± 17.7 mg) relative to controls (14.75 ± 9.88 mg, P < 0.05) and WI-HMP group (12.75 ± 4.5 mg, P < 0.05).
Airdrive Improved Liver Graft Recovery and Animal Survival After Transplantation
All the animals in the WI-SCS group experienced PNF, and died within 6 hours after transplantation. No deaths were due to procedure-related causes. In contrast and like controls, all animals from the WI-HMP group showed full functional recovery and survived until sacrifice at 5 days.
Airdrive Improved Liver Graft Function and Attenuated Liver Cell Damage After Transplantation
After reperfusion, MP livers functioned better than the WI-SCS livers, as reflected by INR profiles and serum bilirubin levels (Figures 2A and B) . Hepatic dysfunction observed in WI-SCS group (Figures 2A and B) was associated with acute renal failure ( Figure 2C ). Recipients from WI-SCS group also developed more severe hepatocellular injury. The increase in transaminases was continuous until death, and the difference with controls was highly significant (Figures 2D  and E) . In contrast, Airdrive caused a marked reduction in enzyme release, the postoperative course of ALT and AST being comparable between MP livers and controls ( Figures 2D  and E) . MP livers also exhibited less endothelial cell injury relative to the WI-SCS group, as evidenced by serum PNP levels ( Figure 2F ).
Airdrive Better Preserved Liver Histology
Histological changes after preservation and reperfusion were in line with hepatocellular and endothelial injury ( Figures 3A and B) . Histology in WI-SCS group revealed marked vascular congestion, sinusoidal dilatation and parenchymal cell loss, predominating in centrilobular areas ( Figures 3A  and B ) and more pronounced after 1 hour reperfusion ( Figure 3B ). The damage score was significantly higher in WI-SCS group relative to controls, either at the end of preservation (22.66 ± 0.74 vs 7.41 ± 0.37; P < 0.05) ( Figure 3C ) or after reperfusion (39.58 ± 1.12 vs 15 ± 0.77; P < 0.05) ( Figure 3D) . A better maintenance of liver integrity was observed in MP livers, compared with WI-SCS group ( Figures 3A  and B) . At 1 hour postreperfusion, we could observe wellpreserved hepatocytes cords with slight sinusoidal dilatation and moderate vascular congestion in WI-HMP group ( Figure 3B ). The damage score in MP livers was significantly lower relative to SC stored livers (P < 0.05), both at the end of the preservation period (24 ± 2 vs 8 ± 1; P < 0.05) ( Figure 3C ) and after 60 minutes of reperfusion (39.58 ± 5 vs 22.33 ± 0.54; P < 0.05) ( Figure 3D ). At 5 days posttransplantation, a microscopic examination of the MP livers showed complete resolution of histological abnormalities, and the MP livers were similar to controls ( Figure S1 A and C, SDC, http:// links.lww.com/TP/B430).
Airdrive Better Maintained Energy Metabolism
The HMP device attenuated depletion of hepatic ATP content during cold preservation and improved ATP recovery after reperfusion compared with WI-SCS group (P < 0.05, Figure 4A ).
Airdrive Attenuated Inflammatory Response
An attenuation of inflammatory response was observed in WI-HMP group, as indicated by a significant reduction in FIGURE 4 . Energy metabolism and inflammatory response. Airdrive attenuated depletion of hepatic ATP content during cold preservation and improved ATP recovery after reperfusion compared to WI-SCS group (P < 0.05) (A). The protective effect of the Airdrive was associated with an attenuation of the inflammatory response as indicated by the reduction in cytokine TNF-α levels both in liver tissue (B) and plasma (C). The data are presented as the mean ± SD from individual experiments. *P < 0.05 versus controls, + P < 0.05 versus WI-SCS. www.transplantjournal.com cytokine TNF-α levels, both in liver tissue ( Figure 4B ) and plasma ( Figure 4C ).
Airdrive Attenuated Oxidative Load and ER Stress
Tissue MDA content was significantly reduced in WI-HMP group, both at the end of preservation and after 60 minutes of reperfusion, thereby translating lower oxidative stress (P < 0.05 vs. WI-SCS, Figure 5A ). MP livers also exhibited higher catalase and SOD activities compared to WI-SCS group (Figures 5B  and C) .HMP also lowered expression of ER stress markers GRP78 and CHOP at 60 minutes postreperfusion ( Figures 5D  and E) . Accordingly, caspase-12 activity was significantly reduced in WI-HMP group at 60 minutes postreperfusion (P < 0.05 vs WI-SCS, Figure 5F ).
Airdrive Better Preserved Mitochondrial Integrity and Protected Against Hepatic Apoptosis
MP livers exhibited lower GLDH activity, cytochrome C, and caspase-9 cleavage release both at the end of preservation and after 60 minutes of reperfusion (P < 0.05 vs WI-SCS, Figures 6A, B, and C) , expressing a better preservation of mitochondrial integrity. Accordingly, the lower levels of cleaved caspase-9 in HMP group were associated with decreased caspase-3 activity (P < 0.05, Figure 6D ). Consequently, Airdrive attenuated hepatic apoptosis as indicated by a significant reduction in the percentage of TUNEL-positive hepatocytes both at the end of preservation (9.4% vs 18.5% in WI-SCS group, P < 0.05) ( Figures 7A and C) , and after 60 minutes of reperfusion (7.5% vs 53.1% in WI-SCS group, P < 0.05) (Figures 7B and D) . 
DISCUSSION
This study demonstrates that oxygenated HMP started immediately after procurement fully rescues the pig liver exposed to lethal ischemic damage in a model of DCD LT, allowing 100% survival rates, along with improved graft function, decreased hepatocellular and endothelial injury, and better-preserved liver histology. In addition to the improved energy metabolism, the protective effect of early perfusion is associated with attenuated inflammatory response, tissue oxidative load, ER stress, mitochondrial damage, and apoptosis.
Several groups are investigating liver MP techniques with different approaches regarding route of perfusion (single vs dual vessel perfusion), oxygenation, perfusate solutions, and temperature. 5, 6, 11, 13, 27 So far, human application of MP remains limited, but promising early experiences have been described using HMP on allografts procured from either brain dead donors 11 or extended criteria donors including DCDs. [12] [13] [14] There has been parallel enthusiasm for normothermic MP. 28 However, it remains unclear whether claimed benefits (the only clinical marker was peak AST) are worth the cost, the complexity, and the known risks of normothermic MP (ie, potential for reperfusion (B, D) . The data are presented as the mean ± SD from individual experiments. *P < 0.05 versus controls, + P < 0.05 versus WI-SCS.
bacterial growth, no backup strategy available in case of mechanical failure). In contrast, HMP offers a protective effect of liver grafts by a simple and practical perfusion technique.
The optimal timing and duration of HMP application remain highly debated. With previously mentioned devices, 11, 13 HMP is started after initial SCS for organ transportation. This approach is termed EIP and has the advantage to be performed in the secured environment of the transplant center with all the support needed. Although EIP is logistically attractive, marked injury may have occurred already to the liver and the biliary tree. 29 We are currently conducting a study using the Airdrive system to compare these 2 strategies, ie, early vs. delay perfusion.
Because it is a lightweight and transportable device, Airdrive permits from a logistical standpoint continuous preservation perfusion from the harvesting location without additional SCS and consequently, allows the prevention or early treatment of graft damage. Animals transplanted with a WI-SCS graft developed severe liver dysfunction and injury as evidenced by histology and transaminases levels, leading to irreversible metabolic acidosis, systemic shock and finally death of all recipients within few hours. In contrast, the use of HMP throughout the preservation period fully prevented these events.
The Airdrive system is simple and reliable since it is based on an oxygen-driven positive displacement pump that allows autoregulation of pressure and flow profiles. Pressurecontrolled perfusion in hypothermic machine liver perfusion is a critical point to minimize the risk of shear stress, mediator release and SEC damage. 9, 30 SEC are also particularly vulnerable to hypothermia which induces serious morphological alterations leading to impaired graft microcirculation, Kupffer cell activation, and adhesion molecules up-regulation. 31 All these disorders contribute to neutrophil infiltration and finally hepatocyte death upon reperfusion. 32 PNP activity was significantly lower in recipients of the WI-HMP group, indicating better preservation of SEC. Serum PNP levels have been shown to be inversely related to SEC viability. 32 Although the exact mechanism remains unclear, an indirect protective effect mediated through improved microcirculation is plausible. It may also reflect a better maintenance of the antioxidant system of livers subjected to I/R injury. 32 Because polyunsaturated fatty acids in the cell membrane are vulnerable to lipid peroxidation, oxidative stress leads to liver cell death very rapidly. 21, 33 This free radical-mediated process was significantly lowered in MP livers, an attenuation that was partly explained by higher catalase and SOD activities. An increase in the activities of both enzymes has been shown to attenuate I/R liver injury. 34 Airdrive also attenuated inflammatory response. Similar findings have been reported by Guarrera et al. 35 In addition to pulsatile dual perfusion, our HMP device provides continuous oxygenation of the perfusion medium. Oxygen supply under hypothermic conditions is a key strategy to decrease reperfusion injury, particularly in organs exposed to WI before procurement, such as DCD livers. 10, 36 The optimal amount of oxygen needed remains unclear. Our system yielded a pO 2 of about 340 mm Hg (ie, 45 kPa) before cannulation of the liver, a level that corresponds to reported levels by others, ranging between 10 and 100 kPa. 37 HMP is 1 way to maintain oxygen supply to the cold organ and therefore its capacity to synthesize ATP, an indispensable energy source to the cell for the maintenance of its structural and functional integrity. 38 ATP is also recognized as an independent risk factor for initial graft dysfunction. 39 In accordance with previous reports, [40] [41] [42] Airdrive improved energy metabolism during cold preservation as well as after reperfusion. This portable HMP device also facilitated ER adaptation. ER stress is an adaptive response to the accumulation of misfolded proteins within the ER. Increasing evidences suggest its implication in the pathogenesis of hepatic I/R injury associated with LT. 43, 44 To further understand the mechanisms leading to liver cell protection, we evaluated mitochondrial damage and apoptotic cell death. Apoptosis is a hallmark of I/R-induced graft damage. 45, 46 Release of cytochrome c from mitochondria is an early event of the apoptotic process in response to oxidative stress. 47, 48 It further induces caspase-9 activation that in turn leads to the activation of the effector caspase-3, a downstream event in the apoptotic cascade. 49 Airdrive attenuated hepatic apoptosis as evidenced by the significant reduction in the percentage of TUNEL-positive hepatocytes as well as decrease of cleaved caspase-3 levels compared to WI-HMP group. The lower GLDH activity, cytochrome c release and caspase-9 cleavage observed in MP livers suggests that mitochondria might also be an important target through which Airdrive exerts its cytoprotective effect. The team of PA Clavien has previously reported mitochondrial protection with HMP. 30 Being disposable, Airdrive minimizes potential infectious hazard. Besides, this device is cost-saving compared to available HMP systems because it does not require important preuse investments, full-time specialized supervision, maintenance, return transport and cleaning.
The design of our study was limited to the analysis of early graft injury and 5-day survival, omitting information on later biliary injury, because this complication typically occurs several weeks after LT. Whether our device also prevents late biliary injury in the setting of DCDs needs further studies.
In conclusion, we show for the first time the efficacy of the HMP Airdrive device to rescue, otherwise lethal, ischemic injured DCD livers in a clinically relevant transplantation model. HMP with Airdrive with cannulation of the liver graft in the donor operating room may help to achieve the full potential of HMP. This novel portable system should also improve results of transplantation from other type of extended criteria donors and allow safe extension of what was previously considered the limits of safe cold preservation for liver allografts.
